Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Avelap 500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Athens Labs Ltd

Salt Composition

Divalproex (500mg)

Overview Avelap 500mg Tablet SR

Epileptic seizures and migraine prophylaxis are key indications for the 500mg sustained-release Avelap tablet. It can also be employed, in certain cases, as a treatment for bipolar disorder, either independently or as part of a combined therapeutic regimen. Dosage and frequency are determined individually by your physician to optimize symptom management. Administer consistently at the same time daily, with or without food, for maximum effectiveness; therapeutic efficacy typically manifests within a couple of weeks. Continuous use, as prescribed, is crucial; discontinuation or missed doses may exacerbate the underlying condition and potentially induce seizures. Abrupt cessation is strongly discouraged. Commonly reported side effects include, but are not limited to: headache, visual blurring, nausea, vomiting, vertigo, fatigue, ataxia, easy bruising, and hypothermia. Most are mild and transient; however, persistent or bothersome symptoms warrant medical consultation. Immediate medical attention is required for any skin rash or redness. Prolonged use carries a risk of osteoporosis and increased fracture susceptibility. Furthermore, while rare, suicidal ideation and behavior are potential adverse events; report any depressive mood changes to your doctor promptly. Prior to initiating treatment, inform your physician of any pre-existing conditions, including cardiac issues, hepatic or renal impairment, urinary difficulties, depression, or a history of suicidal thoughts. Numerous drug interactions are possible; disclose all current medications to ensure treatment safety. Pregnant individuals should consult their doctor before commencing or discontinuing Avelap. Alcohol consumption should be minimized due to potential exacerbation of side effects and increased seizure risk. Regular blood monitoring, both pre- and post-treatment initiation, aids in dose optimization.

Uses of Avelap 500mg Tablet SR

Managing epilepsy and seizures | Bipolar disorder therapy | Migraine prevention

Major Benefits of Avelap 500mg Tablet SR:

Administer this medication precisely as prescribed by your physician, adhering to both dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Avelap 500mg Sustained-Release Tablet can be consumed with or without food, though consistent timing is recommended.

Common Side effects of Avelap 500mg Tablet SR:

  • Decreased body temperature
  • Dizziness
  • Sleepiness
  • Tremors
  • Paresthesia (tingling or pricking sensation)
  • Anemia (low number of red blood cells)
  • Decreased sodium level in blood
  • Liver injury
  • Gastrointestinal disturbance
  • Hypersensitivity
  • Deafness
  • Urinary incontinence
  • Increase in body weight
  • Pain during periods

How to use Avelap 500mg Tablet SR:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Avelap 500mg Sustained-Release Tablets can be consumed with or without food, though consistent timing is recommended.

How Avelap 500mg Tablet SR works:

Depakote ER 500mg tablets are used to manage epilepsy. This anticonvulsant medication works by reducing the overactive electrical signaling in brain neurons, thus controlling seizures.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of Avelap 500mg sustained-release tablets and alcohol may result in significant drowsiness.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Avelap 500mg tablets present a confirmed risk to the unborn child and should not be taken during pregnancy. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential advantages outweigh the known hazards. Medical advice is essential.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Extended-release Avelap 500mg tablets are considered safe for breastfeeding mothers. Research in humans indicates minimal drug transfer into breast milk, posing no known risk to the infant.

DrivingDrivingUNSAFE

Driving ability may be impaired by the use of Avelap 500mg sustained-release tablets, which can produce adverse effects.

KidneyKidneySAFE IF PRESCRIBED

For individuals with kidney impairment, Avelap 500mg sustained-release tablets are considered safe. No alteration of the Avelap 500mg sustained-release tablet dosage is necessary.

LiverLiverUNSAFE

The extended-release Avelap 500mg tablet is likely unsafe for individuals with hepatic impairment and its use should be avoided. Medical advice is recommended.

What if you forget to take Avelap 500mg Tablet SR :

Should you forget to take your Avelap 500mg Tablet SR, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.

Facts to Know About Avelap 500mg Tablet SR

LabelValue
Type of Compound Fatty acid-based compounds
Potential for Dependence None.
Medication Category Nervous System
Mechanism of Action Drugs targeting sodium channels (anti-epileptics)

FAQs on Avelap 500mg Tablet SR

Discontinue Avelap 500mg Tablet SR only after consulting your physician. Withdrawal should be a gradual process, overseen by a healthcare professional, to minimize potential adverse effects. Abrupt cessation may result in symptom relapse, including anxiety, irritability, dizziness, and tremors.
Avelap 500mg sustained-release tablets may be employed in some cases to manage mood instability. Prescribing occurs for individuals exhibiting rapid mood fluctuations. The mechanism involves mitigating excessive brain activity associated with these shifts in mood.
Indeed, Avelap 500mg sustained-release tablets can lead to weight increase. This weight gain may result from heightened appetite. Monitor your diet and engage in regular physical activity to mitigate potential weight gain. For any concerns about weight changes, seek medical advice.
Drowsiness is a potential side effect of Avelap 500mg Tablet SR. Refrain from operating machinery or engaging in activities demanding concentration until you assess its impact on your alertness.
Hair loss is a potential side effect of Avelap 500mg SR tablets; this effect is typically temporary and linked to dosage. If you experience persistent or concerning hair loss, seek medical advice.
Liver damage is a potential adverse effect of Avelap 500mg Tablet SR. This risk is heightened within the initial six months of treatment. Indicators of potential liver injury may involve nausea, vomiting, anorexia, abdominal pain, dark urine, facial edema, and jaundice. Consequently, baseline liver function tests are recommended prior to commencing treatment. Subsequent testing should be conducted regularly throughout the first six months of therapy, particularly for high-risk individuals and patients with pre-existing hepatic conditions.
Refrain from drinking alcohol during your Avelap 500mg Tablet SR treatment course. Concurrent alcohol use may increase drowsiness, lightheadedness, or dizziness.
Prior to commencing Avelap 500mg Tablet SR treatment, your physician might recommend preliminary blood work. This may encompass a complete blood count (including platelets), bleeding time assessment, and coagulation studies. These examinations help prevent unforeseen bleeding or bruising. Furthermore, pre-treatment liver function tests are advisable. Regular liver function monitoring is suggested during the initial six months of treatment, particularly for high-risk individuals and those with a history of liver conditions.
Sudden, intense stomach pain accompanied by nausea and vomiting could indicate pancreatitis. Seek immediate medical attention if these symptoms occur. Your physician may order a serum amylase test. If the test confirms pancreatitis, discontinue the medication at once.
Ingestion of an excessive amount of Avelap 500mg sustained-release tablets can result in headaches, blurred vision from constricted pupils, diminished reflexes, cognitive impairment, and fatigue. Additional symptoms may include muscle weakness or hypotonia, convulsions, unconsciousness, altered behavior, and respiratory problems like tachypnea, dyspnea, or thoracic pain. Seek prompt medical care if an overdose is suspected.
Avelap 500mg Tablet SR
89
MRP 108
17% off